Stopping menopausal hormones may require more bone monitoring
Women face a small rise in fracture risk within 10 years of stopping therapy, suggesting the need for additional monitoring.
Women face a small rise in fracture risk within 10 years of stopping therapy, suggesting the need for additional monitoring.